Print this page
EtodolacOwn Your Copy Today

Etodolac is an indole acetic acid-derivative NSAID labeled for use in dogs to treat pain and inflammation associated with osteoarthritis. It is rapidly absorbed orally, with peak serum concentrations seen 2 hr after dosing. It is primarily eliminated through the bile. The elimination half-life is 8-12 hr. Etodolac appears to be well tolerated by dogs when used at the labeled dosage (10-15 mg/kg, PO, sid) for 1 yr. With multiple doses, clinical signs of toxicity such as GI ulcers, vomiting, diarrhea, and weight loss can be seen at 40 mg/kg. Six of 8 dogs died or became moribund due to GI ulceration at 80 mg/kg.

See Also
Toxicities from Over-the-counter Drugs
Overview
Cold and Cough Medications
Antihistamines
Decongestants
Imidazoline Decongestants
Pseudoephedrine and Ephedrine
Analgesics
Nonsteroidal Anti-inflammatory Drugs (NSAID)
Gastrointestinal Drugs
H2 -Receptor Antagonists
Antacids
Multivitamins and Iron
Topical Preparations
Zinc Oxide
Nutritional Supplements
Ma Huang (Ephedrine) and Guarana (Caffeine)
5-Hydroxytryptophan
Toxicities from Prescription Drugs
Overview
Cardiovascular medications
Overview
Angiotensin-converting Enzyme (ACE) Inhibitors
Calcium Channel Blockers
β Blockers
Diuretics
Tranquilizers, Antidepressants, sleep Aids, and Anticonvulsants
Overview
Benzodiazepines
Antidepressants
Barbiturates
Sleep Aids
Phenothiazine Tranquilizers
Muscle Relaxants
Topical Agents
Overview
5-Fluorouracil
Calcipotriene
Prescription nonsteroidal Anti-inflammatory Drugs
Overview
Carprofen
Deracoxib
Toxicities from Illicit and Abused Drugs
Overview
Cocaine
Amphetamines and Related Drugs
Marijuana (Cannabis)
Opiates